Pituitary disorders. Drug treatment options (Q33863409)

29 July 2017

1 reference

title

Pituitary disorders. Drug treatment options (English)

1 reference

29 July 2017

Orrego JJ

1

1 reference

29 July 2017

Barkan AL

series ordinal

2

1 reference

29 July 2017

publication date

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

59

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

93-106

1 reference

Beneficial effects of high daily dose bromocriptine treatment in Cushing's disease

29 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200059010-00006

Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200059010-00006

21 January 2018

Pituitary insufficiency

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200059010-00006

Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors

21 January 2018

1 reference

12 December 2020

The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.

1 reference

12 December 2020

Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses

1 reference

12 December 2020

Corticosteroid therapy in severe illness

1 reference

12 December 2020

Androgens in men--uses and abuses

1 reference

12 December 2020

Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment

1 reference

12 December 2020

1 reference

12 December 2020

Pergolide for the treatment of pituitary tumors secreting prolactin or growth hormone

1 reference

12 December 2020

A ten-year safety study of the oral androgen testosterone undecanoate.

1 reference

12 December 2020

Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism.

1 reference

12 December 2020

Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects.

1 reference

12 December 2020

CV 205-502 treatment in therapy-resistant acromegalic patients

1 reference

12 December 2020

Current treatment guidelines for acromegaly

1 reference

12 December 2020

Suppression of growth hormone (GH) hypersecretion due to ectopic GH-releasing hormone (GHRH) by a selective GHRH antagonist

1 reference

12 December 2020

Long term effects of continuous subcutaneous infusion of the somatostatin analog octreotide in the treatment of acromegaly

1 reference

12 December 2020

Effects of four years' treatment with biosynthetic human growth hormone (GH) on body composition in GH-deficient hypopituitary adults

1 reference

12 December 2020

Mifepristone: treatment of Cushing's syndrome

1 reference

12 December 2020

Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas

1 reference

12 December 2020

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group

1 reference

12 December 2020

Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas.

1 reference

12 December 2020

Cyproheptadine in Nelson's syndrome

1 reference

12 December 2020

Cyclical Cushing's disease and its successful control under sodium valproate

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of testosterone pellets in man

1 reference

12 December 2020

In vitro and in vivo studies of antagonistic effects of human growth hormone analogs.

1 reference

12 December 2020

Gonadotropin Therapy in Men With Isolated Hypogonadotropic Hypogonadism: The Response to Human Chorionic Gonadotropin Is Predicted by Initial Testicular Size

1 reference

12 December 2020

Effect of different dopaminergic agents in the treatment of acromegaly

1 reference

12 December 2020

A practical guide to prescribing hormone replacement therapy

1 reference

12 December 2020

Size Reduction of Macroprolactinomas by Bromocriptine or Lisuride Treatment*

1 reference

12 December 2020

Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue

1 reference

12 December 2020

Acute effects of bromocriptine, cyproheptadine, and valproic acid on plasma adrenocorticotropin secretion in Nelson's syndrome

1 reference

12 December 2020

Rapid and long-lasting suppression of prolactin secretion and shrinkage of prolactinomas after injection of long-acting repeatable form of bromocriptine (Parlodel LAR)

1 reference

12 December 2020

Size reduction of an ACTH-secreting pituitary macroadenoma in Nelson's syndrome by sodium valproate: effect of withdrawal and re-institution of treatment

1 reference

12 December 2020

Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly

1 reference

12 December 2020

Growth hormone-releasing peptides: clinical and basic aspects

1 reference

12 December 2020

Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee.

1 reference

12 December 2020

Three year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide

1 reference

12 December 2020

Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health.

1 reference

12 December 2020

1 reference

12 December 2020

Thyrotropin-secreting pituitary tumors

1 reference

12 December 2020

Aminoglutethimide in the treatment of Cushing's syndrome

1 reference

12 December 2020

A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men

1 reference

12 December 2020

Medical treatment of prolactinomas

1 reference

12 December 2020

A comparison of octreotide, bromocriptine, or a combination of both drugs in acromegaly

1 reference

12 December 2020

Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly

1 reference

12 December 2020

Cabergoline in the treatment of acromegaly: a study in 64 patients.

1 reference

12 December 2020

Long-term treatment of Nelson's syndrome by octreotide: a case report

1 reference

12 December 2020

Management of pituitary tumors

1 reference

12 December 2020

Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians

1 reference

12 December 2020

Successful treatment of a prolactin-producing pituitary macroadenoma with intravaginal bromocriptine mesylate: a novel approach to intolerance of oral therapy

1 reference

12 December 2020

Orally active growth hormone secretagogues: state of the art and clinical perspectives

1 reference

12 December 2020

1 reference

12 December 2020

A prospective multicenter trial of octreotide in 24 patients with visual defects caused by nonfunctioning and gonadotropin-secreting pituitary adenomas. French Multicenter Octreotide Study Group

1 reference

12 December 2020

The medical treatment of Cushing's syndrome

1 reference

12 December 2020

1 reference

12 December 2020

Follicle-stimulating hormone- and alpha-subunit-secreting pituitary tumor treated with bromocriptine

1 reference

12 December 2020

Octreotide treatment of acromegaly. A randomized, multicenter study

1 reference

12 December 2020

Treatment of prolactin-secreting pituitary macroadenomas with the long-acting non-ergot dopamine agonist CV 205-502.

1 reference

12 December 2020

1 reference

12 December 2020

Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis

1 reference

12 December 2020

1 reference

12 December 2020

Diagnosis and drug therapy of prolactinoma

1 reference

12 December 2020

Glucocorticoid replacement therapy: are patients over treated and does it matter?

1 reference

12 December 2020

An assessment of optimal hydrocortisone replacement therapy

1 reference

12 December 2020

Testosterone buciclate (20 Aet-1) in hypogonadal men: pharmacokinetics and pharmacodynamics of the new long-acting androgen ester

1 reference

12 December 2020

Adrenal insufficiency

1 reference

12 December 2020

The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia.

1 reference

12 December 2020

Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study

1 reference

12 December 2020

Treatment of acromegaly with dopamine agonists

1 reference

12 December 2020

Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine

1 reference

12 December 2020

Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency

1 reference

12 December 2020

Clinical review 85: Emerging issues in androgen replacement therapy

1 reference

12 December 2020

Resistance to bromocriptine in prolactinomas

1 reference

12 December 2020

Long-term therapy with long-acting octreotide (Sandostatin-LAR) for the management of acromegaly.

1 reference

12 December 2020

Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome

1 reference

12 December 2020

Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center study.

1 reference

12 December 2020

Guidelines for optimizing growth hormone replacement therapy in adults

1 reference

12 December 2020

Treatment of Cushing's disease by O,p'DDD. Survey of 62 cases

1 reference

12 December 2020

Transdermal testosterone

1 reference

12 December 2020

Management of prolactinomas

1 reference

12 December 2020

Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study.

1 reference

12 December 2020

Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem

1 reference

12 December 2020

New technique for quantitation of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonadotropin-releasing hormone antagonist

1 reference

12 December 2020

Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group

1 reference

12 December 2020

10.2165/00003495-200059010-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

1007374877

0 references

1 reference